Mutations in CDKN2A and CDK4 in Melanoma Families
Author Information
Author(s): Torre G Della, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot T J G, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti M A
Primary Institution: Istituto Nazionale Tumori
Hypothesis
The study investigates the presence of germ line mutations in the CDKN2A and CDK4 genes in Italian melanoma-prone families.
Conclusion
The study found that inactivating mutations of CDKN2A contribute more to melanoma susceptibility than activating mutations of CDK4.
Supporting Evidence
- One novel disease-associated mutation (P48T) and three known pathological mutations were identified in the CDKN2A gene.
- The overall incidence of CDKN2A mutations was 33.3%, higher in families with three or more melanoma cases (50%).
- Functional analysis showed that the novel mutated protein retains some in vitro binding to CDK4/6.
Takeaway
Researchers looked at families with melanoma to find changes in certain genes, discovering that one gene change makes people more likely to get melanoma.
Methodology
The study analyzed germ line mutations in the CDKN2A and CDK4 genes in 15 Italian melanoma families.
Limitations
The study was conducted on a heterogeneous group of families, which may affect the generalizability of the results.
Participant Demographics
Italian melanoma-prone families.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website